These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1666269)

  • 21. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
    Hickie RA
    Adv Exp Med Biol; 1977 May 22-24; 92():451-88. PubMed ID: 24988
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of the catalytic subunit of protein kinase A with the lung type V cyclic GMP phosphodiesterase: modulation of non-catalytic binding sites.
    Burns F; Pyne NJ
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1389-96. PubMed ID: 1336365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cGMP-phosphodiesterase antagonists inhibit Ca2+-influx in Dictyostelium discoideum and bovine cyclic-nucleotide-gated-channel.
    Lusche DF; Kaneko H; Malchow D
    Eur J Pharmacol; 2005 Apr; 513(1-2):9-20. PubMed ID: 15878705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung.
    Burns F; Rodger IW; Pyne NJ
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):487-91. PubMed ID: 1315515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDE inhibitors: a new approach to treat metabolic syndrome?
    Lugnier C
    Curr Opin Pharmacol; 2011 Dec; 11(6):698-706. PubMed ID: 22018840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages.
    Witwicka H; Kobiałka M; Siednienko J; Mitkiewicz M; Gorczyca WA
    Biochim Biophys Acta; 2007 Feb; 1773(2):209-18. PubMed ID: 17141339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic nucleotide phosphodiesterases.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():1-416. PubMed ID: 6326516
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells.
    Ning H; Xin ZC; Lin G; Banie L; Lue TF; Lin CS
    Urology; 2006 Dec; 68(6):1350-4. PubMed ID: 17169663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical localisation of PDE5 in Leydig and myoid cells of prepuberal and adult rat testis.
    Scipioni A; Stefanini S; Santone R; Giorgi M
    Histochem Cell Biol; 2005 Nov; 124(5):401-7. PubMed ID: 16163485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F; MacLean MR; Pyne NJ
    Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The binding of cyclic nucleotide analogs to a purified cyclic GMP-stimulated phosphodiesterase from bovine adrenal tissue.
    Erneux C; Miot F; Van Haastert PJ; Jastorff B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):463-72. PubMed ID: 2999203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ca2+ induces an increase in cGMP-phosphodiesterase activity in squid retinal photoreceptors.
    Brown JE; Kelman ES
    Biochem Biophys Res Commun; 1996 Jul; 224(3):684-9. PubMed ID: 8713107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
    Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
    Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified cyclic nucleotide systems in Morris hepatoma 3924A favoring expression of cyclic GMP effect.
    Shoji M; Morris HP; Davis CW; Brackett NL; Kuo JF
    Biochim Biophys Acta; 1977 Dec; 500(2):419-24. PubMed ID: 201299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirmation of tyrosine 698 in beta subunit of cGMP phosphodiesterase in patients with retinitis pigmentosa and population of the west of Mexico.
    Núñez-Gutiérrez IC; García-Cruz D; Fragoso-Herrera R; Medina-Lozano C
    Rev Invest Clin; 2006; 58(4):359-61. PubMed ID: 17146947
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS; Cantor E; Ho E; Walega M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different effects of cAMP and cGMP derivatives on the activity of an identified neuron: biochemical and electrophysiological analysis.
    Levitan IB; Norman J
    Brain Res; 1980 Apr; 187(2):415-29. PubMed ID: 6154497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cGMP-phosphodiesterase activity in chemotactic mutants of Dictyostelium discoideum.
    van Haastert PJ; van Lookeren Campagne MM; Ross FM
    FEBS Lett; 1982 Oct; 147(2):149-52. PubMed ID: 6293867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.